Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q85488347 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241221010740.0 | ||
008 | 241221nneanz||abbn n and d | ||
035 | ‡a (WKP)Q85488347 | ||
024 | ‡a 0000-0003-0921-3144 ‡2 orcid | ||
035 | ‡a (OCoLC)Q85488347 | ||
100 | 0 | ‡a J Christopher Love ‡c researcher ‡9 en | |
400 | 0 | ‡a J Christopher Love ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's A method for learning a sparse classifier in the presence of missing data for high-dimensional biological datasets | ||
670 | ‡a Author's A Size-Selective Intracellular Delivery Platform. | ||
670 | ‡a Author's Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer. | ||
670 | ‡a Author's Breast tissue regeneration is driven by cell-matrix interactions coordinating multi-lineage stem cell differentiation through DDR1 | ||
670 | ‡a Author's CBM-04PD-1 EXPRESSION IDENTIFIES EXHAUSTED TUMOR INFILTRATING REGULATORY T CELLS IN GLIOBLASTOMA. | ||
670 | ‡a Author's CBM-05FUNCTIONAL DIFFERENCES BETWEEN PD-1+ AND PD-1– CD4+ T EFFECTOR CELLS IN HEALTHY DONORS AND PATIENTS WITH GLIOBLASTOMA. | ||
670 | ‡a Author's Cell and fluid sampling microneedle patches for monitoring skin-resident immunity | ||
670 | ‡a Author's Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability. | ||
670 | ‡a Author's Challenging the workhorse: Comparative analysis of eukaryotic micro-organisms for expressing monoclonal antibodies | ||
670 | ‡a Author's Development of a High-Throughput Functional Screen Using Nanowell-Assisted Cell Patterning | ||
670 | ‡a Author's Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects | ||
670 | ‡a Author's Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage | ||
670 | ‡a Author's Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme. | ||
670 | ‡a Author's Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis | ||
670 | ‡a Author's Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity. | ||
670 | ‡a Author's Host-Informed Expression of CRISPR Guide RNA for Genomic Engineering in Komagataella phaffii | ||
670 | ‡a Author's Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection | ||
670 | ‡a Author's Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires | ||
670 | ‡a Author's Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus | ||
670 | ‡a Author's Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencing. | ||
670 | ‡a Author's On-demand manufacturing of clinical-quality biopharmaceuticals | ||
670 | ‡a Author's Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing. | ||
670 | ‡a Author's Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects. | ||
670 | ‡a Author's Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies | ||
670 | ‡a Author's Reexamining opportunities for therapeutic protein production in eukaryotic microorganisms. | ||
670 | ‡a Author's Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. | ||
670 | ‡a Author's Single-Cell Detection of Secreted Aβ and sAPPα from Human IPSC-Derived Neurons and Astrocytes. | ||
670 | ‡a Author's Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration | ||
670 | ‡a Author's Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing | ||
670 | ‡a Author's TBIO-18. LIQUID BIOPSY DETECTION OF GENOMIC ALTERATIONS IN PEDIATRIC BRAIN TUMORS FROM CELL FREE DNA IN PERIPHERAL BLOOD, CSF, AND URINE | ||
670 | ‡a Author's TCR sequencing paired with massively parallel 3' RNA-seq reveals clonotypic T cell signatures | ||
670 | ‡a Author's TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage | ||
670 | ‡a Author's Tumor fraction in cell-free DNA as a biomarker in prostate cancer | ||
670 | ‡a Author's Two Vaccines for Induce a B-Cell-Mediated Immune Response | ||
670 | ‡a Author's What Is Your Conceptual Definition of "Cell Type" in the Context of a Mature Organism? | ||
670 | ‡a Author's Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma. | ||
909 | ‡a (orcid) 0000000309213144 ‡9 1 | ||
919 | ‡a methodforlearningasparseclassifierinthepresenceofmissingdataforhighdimensionalbiologicaldatasets ‡A A method for learning a sparse classifier in the presence of missing data for high-dimensional biological datasets ‡9 1 | ||
919 | ‡a sizeselectiveintracellulardeliveryplatform ‡A A Size-Selective Intracellular Delivery Platform. ‡9 1 | ||
919 | ‡a associationofcellfreednatumorfractionandsomaticcopynumberalterationswithsurvivalinmetastatictriplenegativebreastcancer ‡A Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer. ‡9 1 | ||
919 | ‡a breasttissueregenerationisdrivenbycellmatrixinteractionscoordinatingmultilineagestemcelldifferentiationthroughddr1 ‡A Breast tissue regeneration is driven by cell-matrix interactions coordinating multi-lineage stem cell differentiation through DDR1 ‡9 1 | ||
919 | ‡a cbm04pd1expressionidentifiesexhaustedtumorinfiltratingregulatorytcellsinglioblastoma ‡A CBM-04PD-1 EXPRESSION IDENTIFIES EXHAUSTED TUMOR INFILTRATING REGULATORY T CELLS IN GLIOBLASTOMA. ‡9 1 | ||
919 | ‡a cbm05functionaldifferencesbetweenpd1+andpd1cd4+teffectorcellsinhealthydonorsandpatientswithglioblastoma ‡A CBM-05FUNCTIONAL DIFFERENCES BETWEEN PD-1+ AND PD-1– CD4+ T EFFECTOR CELLS IN HEALTHY DONORS AND PATIENTS WITH GLIOBLASTOMA. ‡9 1 | ||
919 | ‡a cellandfluidsamplingmicroneedlepatchesformonitoringskinresidentimmunity ‡A Cell and fluid sampling microneedle patches for monitoring skin-resident immunity ‡9 1 | ||
919 | ‡a celltypedependentalzheimersdiseasephenotypesprobingthebiologyofselectiveneuronalvulnerability ‡A Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability. ‡9 1 | ||
919 | ‡a challengingtheworkhorsecomparativeanalysisofeukaryoticmicroorganismsforexpressingmonoclonalantibodies ‡A Challenging the workhorse: Comparative analysis of eukaryotic micro-organisms for expressing monoclonal antibodies ‡9 1 | ||
919 | ‡a developmentofahighthroughputfunctionalscreenusingnanowellassistedcellpatterning ‡A Development of a High-Throughput Functional Screen Using Nanowell-Assisted Cell Patterning ‡9 1 | ||
919 | ‡a diversityofantiviraliggeffectoractivitiesobservedinhivinfectedandvaccinatedsubjects ‡A Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects ‡9 1 | ||
919 | ‡a erythrocyteefferocytosismodulatesmacrophagestowardsrecoveryafterintracerebralhemorrhage ‡A Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage ‡9 1 | ||
919 | ‡a functionaldifferencesbetweenpd1+andpd1cd4+effectortcellsinhealthydonorsandpatientswithglioblastomamultiforme ‡A Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme. ‡9 1 | ||
919 | ‡a functionalinflammatoryprofilesdistinguishmyelinreactivetcellsfrompatientswithmultiplesclerosis ‡A Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis ‡9 1 | ||
919 | ‡a generationoflonglivedbonemarrowplasmacellssecretingantibodiesspecificforthehiv1gp41membraneproximalexternalregionintheabsenceofpolyreactivity ‡A Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity. ‡9 1 | ||
919 | ‡a hostinformedexpressionofcrisprguidernaforgenomicengineeringinkomagataellaphaffii ‡A Host-Informed Expression of CRISPR Guide RNA for Genomic Engineering in Komagataella phaffii ‡9 1 | ||
919 | ‡a integratedsinglecellanalysisofmulticellularimmunedynamicsduringhyperacutehiv1infection ‡A Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection ‡9 1 | ||
919 | ‡a longitudinalmultiparametersinglecellanalysisofmacaquesimmunizedwithpneumococcalproteinconjugatedorunconjugatedpolysaccharidevaccinesrevealsdistinctantigenspecificmemorybcellrepertoires ‡A Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires ‡9 1 | ||
919 | ‡a molecularengineeringimprovesantigenqualityandenablesintegratedmanufacturingofatrivalentsubunitvaccinecandidateforrotavirus ‡A Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus ‡9 1 | ||
919 | ‡a neutralizingantibodiesagainstwestnilevirusidentifieddirectlyfromhumanbcellsbysinglecellanalysisandnextgenerationsequencing ‡A Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencing. ‡9 1 | ||
919 | ‡a ondemandmanufacturingofclinicalqualitybiopharmaceuticals ‡A On-demand manufacturing of clinical-quality biopharmaceuticals ‡9 1 | ||
919 | ‡a opportunitiesandchallengesofrealtimereleasetestinginbiopharmaceuticalmanufacturing ‡A Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing. ‡9 1 | ||
919 | ‡a peanutoralimmunotherapytransientlyexpandscirculatingarah2specificbcellswithahomologousrepertoireinunrelatedsubjects ‡A Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects. ‡9 1 | ||
919 | ‡a primingagentstransientlyreducetheclearanceofcellfreednatoimproveliquidbiopsies ‡A Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies ‡9 1 | ||
919 | ‡a reexaminingopportunitiesfortherapeuticproteinproductionineukaryoticmicroorganisms ‡A Reexamining opportunities for therapeutic protein production in eukaryotic microorganisms. ‡9 1 | ||
919 | ‡a scalablewholeexomesequencingofcellfreednarevealshighconcordancewithmetastatictumors ‡A Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. ‡9 1 | ||
919 | ‡a singlecelldetectionofsecretedaβandsappαfromhumanipscderivedneuronsandastrocytes ‡A Single-Cell Detection of Secreted Aβ and sAPPα from Human IPSC-Derived Neurons and Astrocytes. ‡9 1 | ||
919 | ‡a singlecelltranscriptomicatlasofthehumanretinaidentifiescelltypesassociatedwithagerelatedmaculardegeneration ‡A Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration ‡9 1 | ||
919 | ‡a structuralalterationsdrivingcastrationresistantprostatecancerrevealedbylinkedreadgenomesequencing ‡A Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing ‡9 1 | ||
919 | ‡a tbio18liquidbiopsydetectionofgenomicalterationsinpediatricbraintumorsfromcellfreednainperipheralbloodcsfandurine ‡A TBIO-18. LIQUID BIOPSY DETECTION OF GENOMIC ALTERATIONS IN PEDIATRIC BRAIN TUMORS FROM CELL FREE DNA IN PERIPHERAL BLOOD, CSF, AND URINE ‡9 1 | ||
919 | ‡a tcrsequencingpairedwithmassivelyparallel3rnaseqrevealsclonotypictcellsignatures ‡A TCR sequencing paired with massively parallel 3' RNA-seq reveals clonotypic T cell signatures ‡9 1 | ||
919 | ‡a tgfβ1modulatesmicroglialphenotypeandpromotesrecoveryafterintracerebralhemorrhage ‡A TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage ‡9 1 | ||
919 | ‡a tumorfractionincellfreednaasabiomarkerinprostatecancer ‡A Tumor fraction in cell-free DNA as a biomarker in prostate cancer ‡9 1 | ||
919 | ‡a 2vaccinesforinduceabcellmediatedimmuneresponse ‡A Two Vaccines for Induce a B-Cell-Mediated Immune Response ‡9 1 | ||
919 | ‡a whatisyourconceptualdefinitionofcelltypeinthecontextofamatureorganism ‡A What Is Your Conceptual Definition of "Cell Type" in the Context of a Mature Organism? ‡9 1 | ||
919 | ‡a wholeexomesequencingofcellfreednaandcirculatingtumorcellsinmultiplemyeloma ‡A Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma. ‡9 1 | ||
996 | ‡2 LC|nr 00024423 | ||
996 | ‡2 SUDOC|194318745 | ||
996 | ‡2 LC|no2019113501 | ||
996 | ‡2 J9U|987007281070605171 | ||
996 | ‡2 J9U|987007335900805171 | ||
996 | ‡2 XA|14812 | ||
996 | ‡2 ISNI|0000000497544628 | ||
996 | ‡2 ISNI|0000000058090839 | ||
996 | ‡2 CAOONL|ncf11187531 | ||
996 | ‡2 LC|n 90641301 | ||
996 | ‡2 BIBSYS|90080990 | ||
996 | ‡2 NII|DA08320151 | ||
996 | ‡2 LC|no2008033358 | ||
996 | ‡2 CAOONL|ncf11523857 | ||
996 | ‡2 LC|no2012072122 | ||
996 | ‡2 ISNI|0000000094720957 | ||
996 | ‡2 ISNI|0000000050570897 | ||
996 | ‡2 NUKAT|n 2006093429 | ||
996 | ‡2 DBC|87097969952860 | ||
996 | ‡2 LC|n 2001011196 | ||
996 | ‡2 ISNI|0000000445337918 | ||
996 | ‡2 LC|n 86067722 | ||
996 | ‡2 CAOONL|ncf11360644 | ||
996 | ‡2 DNB|1191721221 | ||
996 | ‡2 LC|n 94029129 | ||
996 | ‡2 BNF|15034671 | ||
996 | ‡2 LNB|LNC10-000338367 | ||
996 | ‡2 SUDOC|192296418 | ||
996 | ‡2 LC|nb2019000204 | ||
996 | ‡2 DNB|1061327981 | ||
996 | ‡2 NLA|000077141737 | ||
996 | ‡2 CAOONL|ncf10992433 | ||
996 | ‡2 LC|no2015105831 | ||
996 | ‡2 DNB|1140536990 | ||
996 | ‡2 SUDOC|254863213 | ||
996 | ‡2 ISNI|0000000081738795 | ||
996 | ‡2 LC|n 91011125 | ||
996 | ‡2 ISNI|0000000467755141 | ||
996 | ‡2 SUDOC|080535887 | ||
996 | ‡2 ISNI|0000000041413435 | ||
996 | ‡2 NTA|072837683 | ||
996 | ‡2 SUDOC|131291017 | ||
996 | ‡2 LIH|LNB:CF_z__y_;=CM | ||
996 | ‡2 LC|n 93012577 | ||
996 | ‡2 BNF|15760505 | ||
996 | ‡2 LC|no2023045263 | ||
996 | ‡2 NTA|203235533 | ||
996 | ‡2 BIBSYS|9051699 | ||
996 | ‡2 ISNI|0000000497686896 | ||
996 | ‡2 DBC|87097919481964 | ||
996 | ‡2 ISNI|0000000052259883 | ||
996 | ‡2 DBC|87097968648874 | ||
996 | ‡2 DNB|171546326 | ||
996 | ‡2 ISNI|0000000054027736 | ||
996 | ‡2 CAOONL|ncf12125785 | ||
996 | ‡2 RERO|A011826760 | ||
996 | ‡2 NKC|mub2014823130 | ||
996 | ‡2 ISNI|0000000433851418 | ||
996 | ‡2 SUDOC|242160301 | ||
996 | ‡2 ISNI|0000000030374987 | ||
996 | ‡2 SUDOC|169467538 | ||
996 | ‡2 LC|n 2010160371 | ||
996 | ‡2 BNC|981058617780206706 | ||
996 | ‡2 NII|DA19980560 | ||
996 | ‡2 DNB|105543450X | ||
996 | ‡2 NII|DA08382498 | ||
996 | ‡2 NUKAT|n 2011061358 | ||
996 | ‡2 PLWABN|9811342613505606 | ||
996 | ‡2 BNF|17859275 | ||
996 | ‡2 NII|DA14874271 | ||
996 | ‡2 CAOONL|ncf10647760 | ||
996 | ‡2 LC|no2012158328 | ||
996 | ‡2 BNF|10362344 | ||
996 | ‡2 LC|nr2005023237 | ||
996 | ‡2 DNB|1137627743 | ||
996 | ‡2 PLWABN|9810627150005606 | ||
996 | ‡2 LC|no2008168907 | ||
996 | ‡2 BIBSYS|90800615 | ||
996 | ‡2 NTA|160967228 | ||
996 | ‡2 ISNI|000000004215878X | ||
996 | ‡2 LC|n 2016070183 | ||
996 | ‡2 NUKAT|n 2010057647 | ||
996 | ‡2 NYNYRILM|154265 | ||
996 | ‡2 LC|no 00039787 | ||
996 | ‡2 ISNI|0000000377400339 | ||
996 | ‡2 LC|n 2008066271 | ||
996 | ‡2 W2Z|1634281497987 | ||
996 | ‡2 BNF|12106871 | ||
996 | ‡2 LC|n 2008013589 | ||
996 | ‡2 LIH|LNB:C_t__h__w_;=C_g_ | ||
996 | ‡2 LC|n 86014041 | ||
996 | ‡2 LC|no 98125461 | ||
996 | ‡2 UIY|000024582 | ||
996 | ‡2 ISNI|0000000030011617 | ||
996 | ‡2 LC|no 95008376 | ||
996 | ‡2 CAOONL|ncf10280923 | ||
996 | ‡2 ISNI|0000000051361122 | ||
996 | ‡2 ISNI|0000000063727347 | ||
996 | ‡2 BIBSYS|1634281497987 | ||
996 | ‡2 NKC|xx0237315 | ||
996 | ‡2 LC|n 92097296 | ||
996 | ‡2 ISNI|0000000076028326 | ||
996 | ‡2 CAOONL|ncf10886940 | ||
996 | ‡2 SUDOC|115821252 | ||
996 | ‡2 LC|n 2016498186 | ||
996 | ‡2 NUKAT|n 99025305 | ||
996 | ‡2 LC|n 82214891 | ||
996 | ‡2 LC|n 2018049877 | ||
996 | ‡2 CAOONL|ncf11292232 | ||
996 | ‡2 DNB|1045328014 | ||
996 | ‡2 PLWABN|9810597292805606 | ||
996 | ‡2 SUDOC|172767687 | ||
996 | ‡2 ISNI|000000010870908X | ||
996 | ‡2 LC|no2016135849 | ||
996 | ‡2 LC|no2012103480 | ||
996 | ‡2 ISNI|0000000054264766 | ||
996 | ‡2 DNB|104126345 | ||
996 | ‡2 DNB|141886668 | ||
996 | ‡2 PLWABN|9810561336005606 | ||
996 | ‡2 ISNI|0000000082295842 | ||
996 | ‡2 SUDOC|224560352 | ||
996 | ‡2 LC|n 2014015019 | ||
996 | ‡2 LC|nb2007020092 | ||
996 | ‡2 PLWABN|9810583391005606 | ||
996 | ‡2 ISNI|0000000047781263 | ||
996 | ‡2 LC|n 2002103547 | ||
996 | ‡2 NDL|00448085 | ||
996 | ‡2 NDL|00448084 | ||
996 | ‡2 NSK|000345792 | ||
996 | ‡2 LC|n 85144657 | ||
996 | ‡2 LC|no2007057981 | ||
996 | ‡2 NII|DA13542232 | ||
996 | ‡2 ISNI|0000000027695755 | ||
996 | ‡2 RERO|A022883130 | ||
996 | ‡2 DBC|87097991414023 | ||
996 | ‡2 ISNI|0000000495663527 | ||
996 | ‡2 NTA|227460812 | ||
996 | ‡2 NKC|mzk20211100588 | ||
996 | ‡2 BNF|13332004 | ||
996 | ‡2 BIBSYS|99010345 | ||
996 | ‡2 ISNI|0000000117484505 | ||
996 | ‡2 ISNI|0000000024556063 | ||
996 | ‡2 PTBNP|1781732 | ||
996 | ‡2 RERO|A023335903 | ||
996 | ‡2 LC|n 85138827 | ||
996 | ‡2 SUDOC|131535846 | ||
996 | ‡2 RERO|A009587006 | ||
996 | ‡2 LC|nr 93021299 | ||
996 | ‡2 LNB|LNC10-000090983 | ||
996 | ‡2 BIBSYS|12008666 | ||
996 | ‡2 ISNI|0000000031925496 | ||
996 | ‡2 SUDOC|252829034 | ||
996 | ‡2 DNB|140456910 | ||
996 | ‡2 B2Q|0000113527 | ||
996 | ‡2 ARBABN|000045145 | ||
996 | ‡2 J9U|987007340863805171 | ||
996 | ‡2 ISNI|000000008438737X | ||
996 | ‡2 LC|no2017071469 | ||
996 | ‡2 DNB|132854767 | ||
996 | ‡2 J9U|987007432483205171 | ||
996 | ‡2 ISNI|0000000048590493 | ||
996 | ‡2 J9U|987007347046905171 | ||
996 | ‡2 LC|n 50043515 | ||
996 | ‡2 LC|n 2015004845 | ||
996 | ‡2 NTA|099576759 | ||
996 | ‡2 CAOONL|ncf10701022 | ||
996 | ‡2 CAOONL|ncf10592436 | ||
996 | ‡2 LC|n 93801067 | ||
996 | ‡2 J9U|987007376880205171 | ||
996 | ‡2 BNF|15102498 | ||
996 | ‡2 BNF|13978039 | ||
996 | ‡2 DNB|1213052858 | ||
996 | ‡2 SUDOC|098417924 | ||
996 | ‡2 LC|nb 99140328 | ||
996 | ‡2 PLWABN|9813627573605606 | ||
996 | ‡2 DNB|1079691499 | ||
996 | ‡2 NII|DA04425238 | ||
996 | ‡2 LC|n 2009164583 | ||
996 | ‡2 LC|n 2008013336 | ||
996 | ‡2 NTA|171009746 | ||
996 | ‡2 BIBSYS|90238333 | ||
996 | ‡2 SUDOC|224919849 | ||
996 | ‡2 LC|n 82220830 | ||
996 | ‡2 ISNI|0000000054914853 | ||
996 | ‡2 NKC|xx0236037 | ||
996 | ‡2 J9U|987007443794905171 | ||
996 | ‡2 LC|no2015057823 | ||
996 | ‡2 LC|n 84130750 | ||
996 | ‡2 LC|no2010026171 | ||
996 | ‡2 RERO|A026954873 | ||
996 | ‡2 LC|no2007126912 | ||
996 | ‡2 LC|no2023085906 | ||
996 | ‡2 LC|no2009150784 | ||
996 | ‡2 LC|no2005064726 | ||
996 | ‡2 SZ|1140536990 | ||
996 | ‡2 RERO|A029017056 | ||
996 | ‡2 NII|DA01281007 | ||
996 | ‡2 B2Q|0000490240 | ||
996 | ‡2 LC|n 93006870 | ||
996 | ‡2 ISNI|0000000139976105 | ||
996 | ‡2 ISNI|000000011754300X | ||
996 | ‡2 ISNI|0000000032094102 | ||
996 | ‡2 ISNI|0000000040202038 | ||
996 | ‡2 RERO|A012121136 | ||
996 | ‡2 DNB|121613410 | ||
996 | ‡2 LC|nr2006024837 | ||
996 | ‡2 J9U|987007429314105171 | ||
996 | ‡2 ISNI|0000000054751839 | ||
996 | ‡2 RERO|A022927796 | ||
996 | ‡2 NUKAT|n 2019045782 | ||
996 | ‡2 LC|no2017166114 | ||
996 | ‡2 LC|n 88163780 | ||
996 | ‡2 LC|no 96003416 | ||
996 | ‡2 LC|no2017136160 | ||
996 | ‡2 ISNI|0000000073434134 | ||
996 | ‡2 BNF|18165507 | ||
996 | ‡2 ISNI|0000000499609683 | ||
996 | ‡2 LC|no2012156173 | ||
996 | ‡2 CAOONL|ncf10513906 | ||
996 | ‡2 BNF|12256095 | ||
996 | ‡2 ISNI|0000000041898073 | ||
996 | ‡2 ISNI|0000000028101947 | ||
996 | ‡2 NTA|339730501 | ||
996 | ‡2 NTA|267143214 | ||
996 | ‡2 LIH|LNB:DA_s_B;=BQ | ||
996 | ‡2 ISNI|0000000063197294 | ||
996 | ‡2 ISNI|0000000140275576 | ||
996 | ‡2 LC|no2016049941 | ||
996 | ‡2 LC|no2024035314 | ||
996 | ‡2 SUDOC|156910799 | ||
996 | ‡2 LC|no2011002265 | ||
996 | ‡2 LC|n 2012003041 | ||
996 | ‡2 ISNI|0000000083416837 | ||
996 | ‡2 LC|no2009069508 | ||
996 | ‡2 LC|n 2016061917 | ||
996 | ‡2 LC|nr 93021296 | ||
996 | ‡2 LC|nr 93021297 | ||
996 | ‡2 LC|nr 93021295 | ||
996 | ‡2 BLBNB|000280202 | ||
996 | ‡2 BLBNB|000280201 | ||
996 | ‡2 LC|n 00092600 | ||
996 | ‡2 BIBSYS|7054874 | ||
996 | ‡2 DNB|1063743346 | ||
996 | ‡2 LC|n 78004868 | ||
996 | ‡2 NUKAT|n 2007115485 | ||
996 | ‡2 NII|DA07324328 | ||
996 | ‡2 ISNI|0000000047296858 | ||
996 | ‡2 PTBNP|1816839 | ||
996 | ‡2 PLWABN|9812446991005606 | ||
996 | ‡2 DNB|1137297123 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |